<unk>  is overexpressed in prostate cancer (PCa) and is associated with the development of castration-resistant prostate cancer (CRPC). In addition,<unk>  overexpression may serve as a promising biomarker for prostate cancer progression.
AKR1C3
TAAR1
AHDC1
PANO1
AKR1C1
SMN1
SLITRK1
INAH 3